Lung Cancer News and Research

Latest Lung Cancer News and Research

DBS introduces novel Multiplex Immunohistochemistry cancer kits

Diagnostic Biosystems, a specialty Immunohistochemistry company, announces its debut as an automated IHC company, introducing the Mosaic 360 System with a product offering of novel Multiplex Immunohistochemistry kits and a complementary line of optimized IHC reagents.

19 Mar 2012

Study confirms value of Cambridge Heart's MTWA test for SCA

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that a new study published on-line in the Heart Rhythm Journal confirms the value of Microvolt T-Wave Alternans (MTWA) testing for identifying patients at risk of sudden cardiac arrest.

19 Mar 2012

East Asian BIM gene variant contributes to drug resistance in cancer

A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.

19 Mar 2012

U.S. to launch graphic anti-smoking warnings

The United States Government is starting a major new effort to cut the country's smoking rate by showing graphic images of people who have sustained life-altering health problems after smoking for years.

18 Mar 2012

Clinicians to discuss best approaches for future cancer treatment at Brainlab's radiotherapy meeting

Today clinicians from around the world will gather at the 4th Brainlab European Radiotherapy User Meeting to share their best practice and experiences in treating difficult-to-treat cancers using advanced radiotherapy.

17 Mar 2012

LCA comments on CDC's new anti-tobacco campaign

Today, Lung Cancer Alliance (LCA) said that the new anti-tobacco campaign just launched by the Centers for Disease Control and Prevention (CDC) is an important revitalization of the efforts to prevent young people from smoking and encourage all who do smoke to quit.

17 Mar 2012

BRG1 gene loss implies lack of response of cells to retinoic acid and steroids

Retinoic acid (vitamin A) and steroids are hormones found in our body that protect against oxidative stress, reduce inflammation and are involved in cellular differentiation processes. One of the characteristics of tumours is that their cells have lost the ability to differentiate; therefore these hormones have useful properties to prevent cancer. Currently, retinoic acid and steroids are being used to treat some types of leukaemia.

16 Mar 2012

Serious climate change-related health problems will affect the world's population

Worldwide increases in the incidences of asthma, allergies, infectious and cardiovascular diseases will result from a variety of impacts of global climate change, including rising temperatures, worsening ozone levels in urban areas, the spread of desertification, and expansions of the ranges of communicable diseases as the planet heats up, the professional organization representing respiratory and airway physicians stated in a new position paper released today.

16 Mar 2012

CYFRA reliable marker for response to chemotherapy for NSCLC

Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that this marker can be used to determine whether or not a patient should continue a particular chemotherapy regimen.

16 Mar 2012

Panel of 10 serum protein biomarkers could help in lung cancer diagnosis

A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis.

16 Mar 2012

Patients with early stage MPM may be eligible for aggressive multi-modality therapy

Patients with early stage malignant pleural mesothelioma (MPM), a cancer that develops in the lining of the lungs, may be eligible for aggressive multi-modality therapy involving surgery, radiotherapy and chemotherapy.

16 Mar 2012

New technique can sensitize cancer cells to radiation

Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.

16 Mar 2012

Nearly 800,000 lung cancer deaths prevented due to tobacco control efforts

Declines in cigarette smoking among Americans since the mid-1950s - particularly since tobacco-control policies and interventions were implemented after the U.S. Surgeon General's Report on Smoking and Health was released in 1964 - prevented nearly 800,000 lung cancer deaths between 1975 and 2000, according to a study led by researchers at Fred Hutchinson Cancer Research Center.

15 Mar 2012

Agennix, DSM sign new contract to manufacture talactoferrin for NSCLC

DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V., and Agennix AG have signed a new contract under which DSM will continue to manufacture talactoferrin for Agennix at commercial levels.

13 Mar 2012

Scientists develop realistic model to explain cellular signal processing

Scientists at the Charité - Universitätsmedizin Berlin and the US National Institutes of Health (NIH) have developed a realistic model for explaining cellular signal processing.

13 Mar 2012

Cancer rates to fall among men but slightly rise among women by 2020: Report

The report says that due to the growing and ageing population the actual number of new cases will rise by almost 40 per cent on 2007 levels. But when that's converted to the number of cases per 100,000 people the results are surprising. Cancer rates in men will fall from 595 to 568 cases per 100,000 by 2020. That equates to about 85,000 cases. When it comes to women the rate is projected to rise from 394 to 408 cases per 100,000. That's equivalent to 65,000 new cases in 2020.

11 Mar 2012

New ways of delivering personalized cancer therapies in a cost effective manner

As scientists continue making breakthroughs in personalized cancer treatment, delivering those therapies in the most cost effective manner has become increasingly important. Now researchers at the University of Colorado School of Medicine have identified new ways of doing just that, allowing more patients to benefit from this revolution in cancer care.

11 Mar 2012

Surgical intervention can be life-restoring for people with intractable temporal lobe epilepsy

While the thought of any type of surgery can be disconcerting, the thought of brain surgery can be downright frightening. But for people with a particular form of epilepsy, surgical intervention can literally be life-restoring.

8 Mar 2012

Genesys BioLabs introduces PAULA's test for early lung cancer detection

Genesys BioLabs, a division of 20/20 GeneSystems, Inc. announces today the launch of PAULA's test, a blood test for the early detection of lung cancer, addressing the need for a widely useable early detection protocol for asymptomatic patients.

7 Mar 2012

Illumina launches new highly multiplexed cancer panel

Illumina today introduced the TruSeq Amplicon - Cancer Panel, a highly multiplexed panel that will allow researchers to accurately sequence hundreds of the most relevant cancer loci, even in difficult samples such as formalin-fixed, paraffin embedded (FFPE) tumor samples.

From Illumina, Inc. 7 Mar 2012